• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管炎的神经系统并发症。

Neurological complications of vasculitis.

作者信息

Moore P M, Cupps T R

出版信息

Ann Neurol. 1983 Aug;14(2):155-67. doi: 10.1002/ana.410140202.

DOI:10.1002/ana.410140202
PMID:6137994
Abstract

The vasculitides are a group of disorders that include the polyarteritis nodosa group of systemic necrotizing vasculitides, hypersensitivity vasculitis, Wegener's granulomatosis, lymphomatoid granulomatosis, giant cell arteritis, Behçet's disease, and isolated angiitis of the central nervous system. Classification is based on clinical, angiographic, and histological features. The frequency and distribution of neurological involvement vary with the underlying disorder and may provide the initial symptoms. Polyarteritis nodosa and Wegener's granulomatosis may affect both the central and peripheral nervous systems, whereas isolated angiitis of the central nervous system and Behçet's disease affect the central nervous system alone. Neurological dysfunction occurs in 80% of patients with polyarteritis nodosa and fewer than 10% of patients with hypersensitivity vasculitis. The mechanism of neurological dysfunction in the vasculitides is tissue ischemia. The clinical effects of ischemia vary, and symptoms may be transient or prolonged. Mononeuritis multiplex, polyneuropathy, and stroke are frequent complications, but encephalopathies, cranial neuropathies, and brachial plexopathies are seen as well. The occurrence of symptoms late in the course of a disease suggests ischemia resulting from healed, scarred vessels as well as from those that are acutely inflamed; this is the case in Takayasu's arteritis and possibly also in polyarteritis nodosa. Treatment is based on identifying and removing the sensitizing agent when possible. Wegener's granulomatosis requires therapy with cyclophosphamide; temporal arteritis, with corticosteroids. In other vasculitides a balance must be reached between the progression of the disease and the side effects of immunosuppression.

摘要

血管炎是一组疾病,包括结节性多动脉炎等系统性坏死性血管炎、过敏性血管炎、韦格纳肉芽肿、淋巴瘤样肉芽肿、巨细胞动脉炎、白塞病以及中枢神经系统孤立性血管炎。分类基于临床、血管造影和组织学特征。神经受累的频率和分布因潜在疾病而异,可能是首发症状。结节性多动脉炎和韦格纳肉芽肿可累及中枢和周围神经系统,而中枢神经系统孤立性血管炎和白塞病仅累及中枢神经系统。结节性多动脉炎患者中80%会出现神经功能障碍,而过敏性血管炎患者中出现该症状的比例不到10%。血管炎中神经功能障碍的机制是组织缺血。缺血的临床影响各不相同,症状可能是短暂的或持续的。多发性单神经炎、多发性神经病和中风是常见并发症,但脑病、颅神经病变和臂丛神经病变也可见到。疾病后期出现症状提示缺血是由愈合、瘢痕化的血管以及急性炎症血管导致的;高安动脉炎可能就是这种情况,结节性多动脉炎可能也是如此。治疗方法是尽可能识别并去除致敏原。韦格纳肉芽肿需要用环磷酰胺治疗;颞动脉炎则用皮质类固醇治疗。在其他血管炎中,必须在疾病进展和免疫抑制副作用之间找到平衡。

相似文献

1
Neurological complications of vasculitis.血管炎的神经系统并发症。
Ann Neurol. 1983 Aug;14(2):155-67. doi: 10.1002/ana.410140202.
2
[Vasculitis].[血管炎]
Ther Umsch. 1996 Jul;53(7):559-67.
3
Therapy of neurological disorders in systemic vasculitis.系统性血管炎的神经系统疾病治疗
Semin Neurol. 2003 Jun;23(2):207-14. doi: 10.1055/s-2003-41133.
4
Temporal arteritis associated with systemic necrotizing vasculitis.颞动脉炎伴系统性坏死性血管炎。
J Rheumatol. 2003 Oct;30(10):2165-9.
5
Clinical relevance of elevated serum thrombomodulin and soluble E-selectin in patients with Wegener's granulomatosis and other systemic vasculitides.韦格纳肉芽肿病及其他系统性血管炎患者血清血栓调节蛋白和可溶性E选择素升高的临床意义。
Am J Med. 1996 Oct;101(4):387-94. doi: 10.1016/S0002-9343(96)00230-6.
6
Neurologic manifestations of systemic vasculitides.系统性血管炎的神经系统表现。
Semin Neurol. 1994 Dec;14(4):300-6. doi: 10.1055/s-2008-1041089.
7
The vasculitides.
Major Probl Intern Med. 1981;21:1-211.
8
[Non-specific angiitis and the central nervous system].[非特异性血管炎与中枢神经系统]
Rev Neurol (Paris). 1983;139(8-9):467-84.
9
Seasonal variation in the onset of Wegener's granulomatosis, polyarteritis nodosa and giant cell arteritis.韦格纳肉芽肿病、结节性多动脉炎和巨细胞动脉炎发病的季节性变化。
J Rheumatol. 1993 Sep;20(9):1524-6.
10
Vasculitis in children and adolescents.儿童和青少年血管炎
Rheum Dis Clin North Am. 1995 Nov;21(4):1115-36.

引用本文的文献

1
Systemic Neoplastic Cryoglobulinemic Vasculitis Mimics Large Vessel Occlusion: A Case Report.系统性肿瘤性冷球蛋白血症性血管炎模拟大血管闭塞:病例报告。
Neurologist. 2023 Sep 1;28(5):326-328. doi: 10.1097/NRL.0000000000000489.
2
Rheumatoid Cerebral Vasculitis in a Patient in Remission.一名病情缓解患者的类风湿性脑血管炎
Clin Med Insights Case Rep. 2022 Mar 9;15:11795476221083114. doi: 10.1177/11795476221083114. eCollection 2022.
3
Neurological manifestations of polyarteritis nodosa: a tour of the neuroaxis by case series.结节性多动脉炎的神经系统表现:病例系列展示神经轴各处病变。
BMC Neurol. 2021 May 21;21(1):205. doi: 10.1186/s12883-021-02228-2.
4
Behcet's disease with peripheral nervous system involvement successfully treated with golimumab: a case report and review of the literature.伴有周围神经系统受累的贝赫切特病经戈利木单抗治疗成功:病例报告及文献复习。
Rheumatol Int. 2021 Jan;41(1):197-203. doi: 10.1007/s00296-020-04650-0. Epub 2020 Jul 16.
5
Neurological Involvement in Primary Systemic Vasculitis.原发性系统性血管炎的神经系统受累
Front Neurol. 2019 Apr 26;10:430. doi: 10.3389/fneur.2019.00430. eCollection 2019.
6
Cerebral vascular findings in PAPA syndrome: cerebral arterial vasculopathy or vasculitis and a posterior cerebral artery dissecting aneurysm.PAPA综合征中的脑血管表现:脑动脉血管病变或血管炎以及大脑后动脉夹层动脉瘤。
BMJ Case Rep. 2015 Jun 24;2015:bcr2015011753. doi: 10.1136/bcr-2015-011753.
7
Giant cell arteritis: the importance of immediate and appropriate diagnosis and treatment for better prognosis.巨细胞动脉炎:及时且恰当的诊断与治疗对改善预后的重要性。
Clin Ophthalmol. 2012;6:909-13. doi: 10.2147/OPTH.S24572. Epub 2012 Jun 13.
8
Cerebral vasculitis in a child with Henoch-Schönlein purpura and familial Mediterranean fever.一名患有过敏性紫癜和家族性地中海热的儿童的脑血管炎
Clin Rheumatol. 2007 Oct;26(10):1729-32. doi: 10.1007/s10067-006-0485-x. Epub 2007 Jan 19.
9
Mononeuritis multiplex as a presenting feature of Wegener granulomatosis: a case report.
Clin Rheumatol. 2007 Aug;26(8):1389-90. doi: 10.1007/s10067-006-0413-0. Epub 2006 Nov 18.
10
Classic polyarteritis nodosa presenting rare clinical manifestations in a patient with hemophilia A.
Int J Hematol. 2006 Jun;83(5):420-5. doi: 10.1532/IJH97.05185.